BGLT3

RNA — tumor vs normal
Tumor vs NormalRNABox plot · TCGA cohorts

Across TCGA pan-cancer cohorts, BGLT3 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of BGLT3’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where BGLT3 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types BGLT3 is over-expressed in tumor.

KIRC are the cancer types where BGLT3 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in BGLT3 RNA (log2); positive values indicate higher expression in tumor. p-values are from the differential-expression test.
LineageGenderStageFold-changepSampling consensus
KIRCMaleAll+0.006.0431view →
Pink = over-expressed in tumor, green = repressed in tumor. Showing the 1 strongest of 1 lineages.

BGLT3–KIRC

Tumor-vs-normal expression box plot for BGLT3 RNA in KIRC.

Open the KIRC breakdown →

Exploration